icrf 193 has been researched along with Chronic Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, D; Dang, X; El Gazzar, M; Khanal, S; Li, Z; Moorman, JP; Morrison, ZD; Nguyen, LN; Nguyen, LNT; Ning, S; Ogbu, SC; Schank, M; Thakuri, BKC; Wang, L; Wang, Z; Wu, XY; Yao, ZQ; Zhang, J; Zhao, J | 1 |
| Adamcová, M; Holečková, M; Jirkovská, A; Karabanovich, G; Kocúrová-Lengvarská, J; Kollárová-Brázdová, P; Kubeš, J; Lenčová-Popelová, O; Mazurová, Y; Roh, J; Šimůnek, T; Štěrba, M; Štěrbová-Kovaříková, P; Váňová, N | 1 |
2 other study(ies) available for icrf 193 and Chronic Disease
| Article | Year |
|---|---|
Inhibition of topoisomerase IIA (Top2α) induces telomeric DNA damage and T cell dysfunction during chronic viral infection.
Topics: Adult; Aged; Apoptosis; CD4-Positive T-Lymphocytes; Chronic Disease; Diketopiperazines; DNA Damage; DNA Repair; DNA Topoisomerases, Type II; DNA-Binding Proteins; Etoposide; Female; Humans; Male; Middle Aged; Phosphoric Diester Hydrolases; Piperazines; Poly (ADP-Ribose) Polymerase-1; Telomerase; Telomere; Telomeric Repeat Binding Protein 2; Topoisomerase II Inhibitors; Virus Diseases; Young Adult | 2020 |
Prodrug of ICRF-193 provides promising protective effects against chronic anthracycline cardiotoxicity in a rabbit model in vivo.
Topics: Animals; Cardiomyopathies; Cardiotoxicity; Chronic Disease; Daunorubicin; Diketopiperazines; Disease Models, Animal; DNA Damage; Fibrosis; HL-60 Cells; Humans; Male; Myocytes, Cardiac; Prodrugs; Rabbits; Topoisomerase II Inhibitors; Tumor Suppressor Protein p53; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2021 |